{"id":792978,"date":"2024-12-05T16:40:31","date_gmt":"2024-12-05T21:40:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/"},"modified":"2024-12-05T16:40:31","modified_gmt":"2024-12-05T21:40:31","slug":"bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/","title":{"rendered":"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic"},"content":{"rendered":"
\n

RICHMOND, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) — BioAge Labs (Nasdaq: BIOA) (\u201cBioAge\u201d, \u201cthe Company\u201d), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Goldman Sachs Second Annual \u201cYear-Ahead\u201d Catalyst Clinic on Thursday, December 19, 2024, 11\u201312 PM EST.<\/p>\n

To access the live webcast of the virtual presentation, register here<\/u><\/a>. Replays of the webcast will be available in the investor section of the Company\u2019s website at https:\/\/ir.bioagelabs.com<\/u><\/a>, and will be archived for 30 days following the presentation.<\/p>\n

\n About BioAge Labs, Inc.<\/strong>
\n
BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. BioAge\u2019s lead product candidate, azelaprag, is an orally available small molecule agonist of APJ that was observed to promote metabolism and prevent muscle atrophy on bed rest in a Phase 1b clinical trial. In mid-2024, BioAge initiated a Phase 2 trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. Azelaprag has potential as an oral regimen to amplify weight loss and improve body composition in patients on obesity therapy with incretin drugs. BioAge is also developing orally available small molecule brain penetrant NLRP3 inhibitors for the treatment of diseases driven by neuroinflammation. BioAge\u2019s preclinical programs, based on novel insights from the company\u2019s discovery platform built on human longevity data, address key pathways in metabolic aging.<\/p>\n

\n Contacts<\/strong>
\n
PR: Chris Patil, media@bioagelabs.com
IR: Elena Liapounova, ir@bioagelabs.com
Partnering: partnering@bioagelabs.com
Web: https:\/\/bioagelabs.com<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

RICHMOND, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) — BioAge Labs (Nasdaq: BIOA) (\u201cBioAge\u201d, \u201cthe Company\u201d), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Goldman Sachs Second Annual \u201cYear-Ahead\u201d Catalyst Clinic on Thursday, December 19, 2024, 11\u201312 PM EST. To access the live webcast of the virtual presentation, register here. Replays of the webcast will be available in the investor section of the Company\u2019s website at https:\/\/ir.bioagelabs.com, and will be archived for 30 days following the presentation. About BioAge Labs, Inc. BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of … <\/p>\n

Continue reading “BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-792978","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RICHMOND, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) — BioAge Labs (Nasdaq: BIOA) (\u201cBioAge\u201d, \u201cthe Company\u201d), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Goldman Sachs Second Annual \u201cYear-Ahead\u201d Catalyst Clinic on Thursday, December 19, 2024, 11\u201312 PM EST. To access the live webcast of the virtual presentation, register here. Replays of the webcast will be available in the investor section of the Company\u2019s website at https:\/\/ir.bioagelabs.com, and will be archived for 30 days following the presentation. About BioAge Labs, Inc. BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of … Continue reading "BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-05T21:40:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNDQ4OCM2NjIzODgxIzIyMDI0ODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic\",\"datePublished\":\"2024-12-05T21:40:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/\"},\"wordCount\":274,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNDQ4OCM2NjIzODgxIzIyMDI0ODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/\",\"name\":\"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNDQ4OCM2NjIzODgxIzIyMDI0ODA=\",\"datePublished\":\"2024-12-05T21:40:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNDQ4OCM2NjIzODgxIzIyMDI0ODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNDQ4OCM2NjIzODgxIzIyMDI0ODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/","og_locale":"en_US","og_type":"article","og_title":"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic - Market Newsdesk","og_description":"RICHMOND, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) — BioAge Labs (Nasdaq: BIOA) (\u201cBioAge\u201d, \u201cthe Company\u201d), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Goldman Sachs Second Annual \u201cYear-Ahead\u201d Catalyst Clinic on Thursday, December 19, 2024, 11\u201312 PM EST. To access the live webcast of the virtual presentation, register here. Replays of the webcast will be available in the investor section of the Company\u2019s website at https:\/\/ir.bioagelabs.com, and will be archived for 30 days following the presentation. About BioAge Labs, Inc. BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of … Continue reading \"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-05T21:40:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNDQ4OCM2NjIzODgxIzIyMDI0ODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic","datePublished":"2024-12-05T21:40:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/"},"wordCount":274,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNDQ4OCM2NjIzODgxIzIyMDI0ODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/","name":"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNDQ4OCM2NjIzODgxIzIyMDI0ODA=","datePublished":"2024-12-05T21:40:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNDQ4OCM2NjIzODgxIzIyMDI0ODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNDQ4OCM2NjIzODgxIzIyMDI0ODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioage-labs-to-present-at-goldman-sachs-year-ahead-catalyst-clinic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioAge Labs to Present at Goldman Sachs \u201cYear-Ahead\u201d Catalyst Clinic"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/792978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=792978"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/792978\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=792978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=792978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=792978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}